Select Page
David pitching at Japan Roadshow, in October 2024.

Last year saw Adoram being well represented by its co-CEO David Pejoski and Hesham Hamed on various national and international events, pitching on the following Biotech events:

  • SwissBiotech Association CEO Forum, Jan 26
  • Sachs European Life Sciences Forum, Zurich, Feb 28-29
  • Start Summit, St-Gallen, 21-22 March
  • SwissBiotech Association Day, Basel. Apr 22-23
  • 24th Annual Biotech in Europe Forum, 25-26th of September
  • BioEurope, Stockholm, Sweeden, November 4-6
  • Investival LSX, London LifeSciences Week, Nov 18
  • RESI Redefining Early Stage Investments conference, London, Dec 3-4
  • BioBusiness Lugano & SwissMedic Basel, USI, Lugano. Nov 28

In addition to pitching at Biotech events, Adoram also attended several academic and clinical meetings, including:

  • Swiss Group for Clinical Cancer Research (SAKK) semi-annual meeting, Adoram clinical plans, June 26-27
  • 2nd European Purine Meeting, Ferrara, Italy. Sep 4-6, 2024
  • Swiss Society for Allergology and Immunology (SSAI), Annual Congress, Geneva, Switzerland. Sep 12, 2024
  • European Society for Medical Oncology (ESMO) ImmunoOncology Annual meeting, Geneva, Switzerland. Dec 11-13, 2024

The whole Adoram team had an exciting year in 2024 and looks forward to 2025 to share more scientific news !